Page last updated: 2024-11-01

norfloxacin and Bordetella pertussis Infection, Respiratory

norfloxacin has been researched along with Bordetella pertussis Infection, Respiratory in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
"Cinoxacin was only moderately active (MIC90 4."1.27Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs. ( Appleman, ME; Gaines, JK; Hadfield, TL; Winn, RE, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appleman, ME1
Hadfield, TL1
Gaines, JK1
Winn, RE1

Other Studies

1 other study available for norfloxacin and Bordetella pertussis Infection, Respiratory

ArticleYear
Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
    Diagnostic microbiology and infectious disease, 1987, Volume: 8, Issue:2

    Topics: Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; E

1987